Workflow
Building and Heavy Construction
icon
Search documents
Taco Bell Parent, Data Center Play And Two Other Stocks Weather War Storm, Hover Near Highs
Investors· 2026-03-06 20:17
Group 1: Argan Inc. (AGX) - Argan reached an all-time high of 469.88 before pulling back to its 21-day moving average, driven by demand for power plants due to artificial intelligence data centers [1] - The company reported a $3 billion backlog in Q3 ended October 31, with earnings growth decelerating by 9% to $2.17 per share year over year, while sales declined 2% to $251.2 million [1] - Argan's Relative Strength Rating of 97 indicates strong performance compared to other stocks in the Investor's Business Daily database over the past 52 weeks [1] Group 2: Yum Brands (YUM) - Yum Brands, the parent company of Taco Bell, Pizza Hut, and KFC, has retreated from a buy zone above a buy point of 163.30, having previously reached an all-time high of 169.39 in late February [1] - The company reported fourth-quarter earnings of $1.73 per share on $2.5 billion in global sales, with same-store sales growth for Taco Bell and KFC [1] - Yum Brands added 1,814 new restaurants across its brands during the quarter, but ranks 92nd among 197 industry groups in the retail-restaurants category [1] Group 3: PPL Corp. (PPL) - PPL Corp. shares have fallen below a breakout point of 38.27 after touching levels last seen in 2017 [1] - The company reported accelerating earnings growth of 41 cents per share with sales of $2.3 billion for its fourth quarter [1] - PPL projects 2026 earnings of $1.94 per share at the midpoint and has extended its annual earnings growth target of 7% through 2029 [1] Group 4: Jazz Pharmaceuticals (JAZZ) - Jazz Pharmaceuticals hit an all-time high of 198 in February and is currently just below a buy point of 182.99 [1] - The company posted fourth-quarter earnings of $6.64 per share and sales of $1.2 billion, with sales growth increasing for the third consecutive quarter [1] - Jazz's 2026 sales outlook is projected at $4.38 billion at the midpoint, outperforming 89% of other stocks in the IBD database over the past 52 weeks [1]